VolitionRX (NYSEAMERICAN:VNRX) Announces Quarterly Earnings Results

Share on StockTwits

VolitionRX (NYSEAMERICAN:VNRX) released its quarterly earnings results on Monday. The medical research company reported ($0.11) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.01, Morningstar.com reports.

NYSEAMERICAN:VNRX opened at $3.92 on Wednesday. VolitionRX has a 12 month low of $1.67 and a 12 month high of $4.65.

In related news, Director Martin Charles Faulkes acquired 70,731 shares of the stock in a transaction dated Monday, June 10th. The stock was acquired at an average cost of $3.02 per share, for a total transaction of $213,607.62. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

A hedge fund recently bought a new stake in VolitionRX stock. Virtu Financial LLC bought a new stake in shares of VolitionRX Ltd (NYSEAMERICAN:VNRX) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 10,794 shares of the medical research company’s stock, valued at approximately $35,000.

VolitionRX Company Profile

VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRX Limited is based in Singapore.

Featured Story: What is Compound Interest?

Earnings History for VolitionRX (NYSEAMERICAN:VNRX)

Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Spotify  Holdings Lifted by Prime Capital Investment Advisors LLC
Spotify Holdings Lifted by Prime Capital Investment Advisors LLC
Inogen Inc  Expected to Announce Earnings of $0.23 Per Share
Inogen Inc Expected to Announce Earnings of $0.23 Per Share
AMN Healthcare Services, Inc.  Given Consensus Rating of “Buy” by Brokerages
AMN Healthcare Services, Inc. Given Consensus Rating of “Buy” by Brokerages
$4.09 Billion in Sales Expected for General Mills, Inc.  This Quarter
$4.09 Billion in Sales Expected for General Mills, Inc. This Quarter
Endeavour Silver Corp  Receives $2.75 Consensus Target Price from Brokerages
Endeavour Silver Corp Receives $2.75 Consensus Target Price from Brokerages
Brokerages Set Alamos Gold Inc  Target Price at $6.77
Brokerages Set Alamos Gold Inc Target Price at $6.77


© 2006-2019 Ticker Report